DHODH-IN-17
Based on 1 Customer Validation
DHODH-IN-17, a 2-anilino nicotinic acid, is a human DHODH inhibitor (IC50=0.40 μM). DHODH-IN-17 can be used for theresearch of acute myeloid leukemia (AML).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.24%
- CAS No.: 16344-26-6
- 화학식: C12H9ClN2O2
- 분자량:248.67
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
HY-137463
AG-636DHODH Inhibitor -
HY-153112
DHODH-IN-23DHODH Inhibitor -
HY-129239
FarudodstatDHODH Inhibitor -
HY-100688
ML390DHODH Inhibitor -
HY-139189
JNJ-74856665DHODH Inhibitor -
HY-128787
hDHODH-IN-4DHODH Inhibitor -
HY-135570
hDHODH-IN-3HsDHODH Inhibitor -
HY-132174
CHIKV-IN-2CHIKV Inhibitor -
HY-135675
DHODH-IN-11Rat DHODH Inhibitor -
HY-112645
BAY-2402234DHODH Inhibitor -
HY-101813
LaflunimusImmunomodulator/DHODH Inhibitor -
HY-132170
DSM502DHODH Inhibitor
Biological Activity
제품 설명
IC50 & Target
IC50: 0.4 μM (DHODH)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Bone marrow cell | EC50 |
3 μM
Compound: 1
|
Induction of bone marrow cell differentiation isolated from ER-HOXA9 fusion protein expressed mouse harboring GFP-lysozyme assessed as upregulation of CD11b/MAC1 after 4 days by flow cytometry
Induction of bone marrow cell differentiation isolated from ER-HOXA9 fusion protein expressed mouse harboring GFP-lysozyme assessed as upregulation of CD11b/MAC1 after 4 days by flow cytometry
|
[PMID: 27994748] |
| THP-1 | EC50 |
10.7 μM
Compound: 1
|
Induction of human THP1 cell differentiation after 4 days by flow cytometry
Induction of human THP1 cell differentiation after 4 days by flow cytometry
|
[PMID: 27994748] |
| U-937 | EC50 |
6.1 μM
Compound: 1
|
Induction of human U937 cell differentiation after 4 days by flow cytometry
Induction of human U937 cell differentiation after 4 days by flow cytometry
|
[PMID: 27994748] |
In Vitro
DHODH-IN-17, a 2-anilino nicotinic acid, is a human DHODH inhibitor with an IC50 value of 0.40 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 16344-26-6
-
Appearance Solid
-
분자량 248.67
-
화학식 C12H9ClN2O2
-
Color Off-white to gray
-
SMILES
O=C(C1=CC=CN=C1NC2=CC=C(Cl)C=C2)O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
용액&용해도
In Vitro:
DMSO : 83.33 mg/mL (335.10 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.67 mg/mL (6.72 mM); Clear solution
This protocol yields a clear solution of ≥ 1.67 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1.67 mg/mL (6.72 mM); Clear solution
This protocol yields a clear solution of ≥ 1.67 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (271 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0214 mL | 20.1070 mL | 40.2139 mL | 100.5348 mL |
| 5 mM | 0.8043 mL | 4.0214 mL | 8.0428 mL | 20.1070 mL | |
| 10 mM | 0.4021 mL | 2.0107 mL | 4.0214 mL | 10.0535 mL | |
| 15 mM | 0.2681 mL | 1.3405 mL | 2.6809 mL | 6.7023 mL | |
| 20 mM | 0.2011 mL | 1.0053 mL | 2.0107 mL | 5.0267 mL | |
| 25 mM | 0.1609 mL | 0.8043 mL | 1.6086 mL | 4.0214 mL | |
| 30 mM | 0.1340 mL | 0.6702 mL | 1.3405 mL | 3.3512 mL | |
| 40 mM | 0.1005 mL | 0.5027 mL | 1.0053 mL | 2.5134 mL | |
| 50 mM | 0.0804 mL | 0.4021 mL | 0.8043 mL | 2.0107 mL | |
| 60 mM | 0.0670 mL | 0.3351 mL | 0.6702 mL | 1.6756 mL | |
| 80 mM | 0.0503 mL | 0.2513 mL | 0.5027 mL | 1.2567 mL | |
| 100 mM | 0.0402 mL | 0.2011 mL | 0.4021 mL | 1.0053 mL |
DHODH-IN-17 Related Classifications
HY-128068 Related Classifications
Powered by Bioz